Case Series: “Silent” Spinal Epidural Metastases in Metastatic Castrate-Resistant Prostate Cancer

por Sabanathan, Dhanusha, Parsonson, Andrew O., Park, John J., Gurney, Howard
Publicado 2023

Cytoreductive nephrectomy for metastatic renal cell carcinoma: inequities in access exist despite improved survival

por Patel, Manish I., Beattie, Kieran, Bang, Albert, Gurney, Howard, Smith, David P.
Publicado 2017

The Adverse Effects of Androgen Deprivation Therapy in Prostate Cancer and the Benefits and Potential Anti-oncogenic Mechanisms of Progressive Resistance Training

por Lam, Teresa, Birzniece, Vita, McLean, Mark, Gurney, Howard, Hayden, Amy, Cheema, Birinder S.
Publicado 2020

Radioimmunotherapy for solid tumors: spotlight on Glypican-1 as a radioimmunotherapy target

por Sabanathan, Dhanusha, Lund, Maria E., Campbell, Douglas H., Walsh, Bradley J., Gurney, Howard
Publicado 2021

Communicating risk in active surveillance of localised prostate cancer: a protocol for a qualitative study

por Rapport, Frances, Hogden, Anne, Gurney, Howard, Gillatt, David, Bierbaum, Mia, Shih, Patti, Churruca, Kate
Publicado 2017

Clinical evidence and insights supporting the use of avelumab first‐line maintenance treatment in patients with advanced urothelial carcinoma in the Asia‐Pacific region

por Eto, Masatoshi, Lee, Jae‐Lyun, Chang, Yen‐Hwa, Gao, Seasea, Singh, Manmohan, Gurney, Howard
Publicado 2022

Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment

por Attard, Gerhardt, Borre, Michael, Gurney, Howard, Loriot, Yohann, Andresen-Daniil, Corina, Kalleda, Ranjith, Pham, Trinh, Taplin, Mary-Ellen
Publicado 2018

Five‐year survival and clinical correlates among patients with advanced non‐small cell lung cancer, melanoma and renal cell carcinoma treated with immune check‐point inhibitors in...

por Brown, Lauren J, da Silva, Ines Pires, Moujaber, Tania, Gao, Bo, Hui, Rina, Gurney, Howard, Carlino, Matteo, Nagrial, Adnan
Publicado 2022

Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviews

por van Leeuwen, Marina T, Luu, Steven, Gurney, Howard, Brown, Martin R, Webber, Kate, Pearson, Sallie-Anne, Hunt, Lee, Vajdic, Claire M
Publicado 2018

Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study

por Daniels, Benjamin, Aslam, Maria, van Leeuwen, Marina T., Brown, Martin, Hunt, Lee, Gurney, Howard, Tang, Monica, Pearson, Sallie-Anne, Vajdic, Claire M.
Publicado 2023

LITESPARK-024: A randomized phase 1/2 study of belzutifan with or without palbociclib for previously treated advanced renal cell carcinoma

por McDermott, David F, Peer, Avivit, Agarwal, Neeraj, Atkins, Michael B, Cornell, Jerry, Perini, Rodolfo F, Grossmann, Kenneth F, Gurney, Howard
Publicado 2023

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers

por Hopkins, Ashley M, Rowland, Andrew, Kichenadasse, Ganessan, Wiese, Michael D, Gurney, Howard, McKinnon, Ross A, Karapetis, Chris S, Sorich, Michael J
Publicado 2017

Insulin-like growth factor role in determining the anti-cancer effect of metformin: RCT in prostate cancer patients

por Birzniece, Vita, Lam, Teresa, McLean, Mark, Reddy, Navneeta, Shahidipour, Haleh, Hayden, Amy, Gurney, Howard, Stone, Glenn, Hjortebjerg, Rikke, Frystyk, Jan
Publicado 2022

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia

por Carus, Andreas, Gurney, Howard, Gebski, Val, Harnett, Paul, Hui, Rina, Kefford, Richard, Wilcken, Nicholas, Ladekarl, Morten, von der Maase, Hans, Donskov, Frede
Publicado 2013

Nuances to precision dosing strategies of targeted cancer medicines

por Hopkins, Ashley M., Menz, Bradley D., Wiese, Michael D., Kichenadasse, Ganessan, Gurney, Howard, McKinnon, Ross A., Rowland, Andrew, Sorich, Michael J.
Publicado 2020

A potent liver-mediated mechanism for loss of muscle mass during androgen deprivation therapy

por Lam, Teresa, McLean, Mark, Hayden, Amy, Poljak, Anne, Cheema, Birinder, Gurney, Howard, Stone, Glenn, Bahl, Neha, Reddy, Navneeta, Shahidipour, Haleh, Birzniece, Vita
Publicado 2019

Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic Reviews

por Van Leeuwen, Marina T, Luu, Steven, Gurney, Howard, Brown, Martin R, Pearson, Sallie-Anne, Webber, Kate, Hunt, Lee, Hong, Soojung, Delaney, Geoffrey P, Vajdic, Claire M
Publicado 2020

Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer

por Lin, Hui-Ming, Mahon, Kate L, Spielman, Calan, Gurney, Howard, Mallesara, Girish, Stockler, Martin R, Bastick, Patricia, Briscoe, Karen, Marx, Gavin, Swarbrick, Alexander, Horvath, Lisa G
Publicado 2017

Androgen deprivation in prostate cancer: benefits of home-based resistance training

por Lam, Teresa, Cheema, Birinder, Hayden, Amy, Lord, Stephen R., Gurney, Howard, Gounden, Shivanjini, Reddy, Navneeta, Shahidipour, Haleh, Read, Scott, Stone, Glenn, McLean, Mark, Birzniece, Vita
Publicado 2020

Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up

por Powles, Thomas, Park, Se Hoon, Caserta, Claudia, Valderrama, Begoña P., Gurney, Howard, Ullén, Anders, Loriot, Yohann, Sridhar, Srikala S., Sternberg, Cora N., Bellmunt, Joaquim, Aragon-Ching, Jeanny B., Wang, Jing, Huang, Bo, Laliberte, Robert J., di Pietro, Alessandra, Grivas, Petros
Publicado 2023